The United States refuses to agree to patent waivers for COVID-19 tests and treatments this year, saying more information is needed to make a sound decision.
The Office of the U.S. Trade Representative announced its support on Tuesday for trade ministers putting off a decision on the World Trade Organization's long-running debate over a waiver for some intellectual property protections.